Mark Danchak Joins WorldQuant Ventures as Managing Director

Seasoned investor and entrepreneur expands firm’s leadership

OLD GREENWICH, Conn.--(BUSINESS WIRE)-- WorldQuant Ventures, a leading early stage investment firm, today announced that Mark Danchak has joined the firm as Managing Director. Mark will co-run the firm with Steven Lau, Managing Director at WorldQuant Ventures.

Mark joined WorldQuant Ventures from Carbon6 Ventures, where he was a Partner and focused on Seed to A Round investments in early stage technology companies. Prior to Carbon6 Ventures, Mark served in senior positions at Harbinger Capital Partners and 24/7 Real Media.

“I have had the pleasure of co-investing with Mark in several of our current portfolio companies,” said Steven. “Mark brings with him over 20 years of experience as an investor and entrepreneur. His deep understanding of the technology landscape and expertise in finding and mentoring early stage technology companies make him a valuable asset for our firm, and our portfolio companies.”

WorldQuant Ventures has expanded its portfolio to over 40 companies across the technology sector.

About WorldQuant Ventures LLC

WorldQuant Ventures LLC is an investment firm founded in 2014 as a private investment vehicle for WorldQuant, LLC’s Founder, Chairman and CEO Igor Tulchinsky. The firm is focused on disruptive companies in technology, with a particular focus on data and finance, and has investments in over 40 companies. WorldQuant Ventures LLC is a separate entity from WorldQuant, LLC, a global quantitative investment management firm. For more information, please visit www.WorldQuantVentures.com and www.WeAreWorldQuant.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171120005667/en/

Media Contact
Katie Crallé / Christina Tilt
Brunswick Group
[email protected]
+1 212-333-3810

Source: WorldQuant Ventures LLC

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• A Dutch Child’s Memories of World War II Resurface Through the Lens of 9/11 in a Powerful New Memoir by Anneke F. Mendiola
• Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.
• Beijing Review: Progress Through Participation